Axogen logo

AxogenAXGN

NASDAQ

Electromedical Equipment

$44.97+0.16%

No cached AI snapshot yet for AXGN.

Be the first to run a multi-agent analysis on this ticker.

Key Stats

$1.86BMarket cap
$45.8352-week high
$9.2252-week low
1,154,615Avg volume (30d)

622 employees51.90M shares outstandinglisted 1986-12-17

Next earnings ~May 5, 2026 · Ex-dividend Jan 27, 2010 · Dividend $1.00 irregular

About Axogen

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Latest News

Showing market-wide stock news

Related Stocksin Electromedical Equipment

Ready to see the live AI view on AXGN?

Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing AXGN side-by-side with live signals.

Axogen (AXGN) Where Next? Multi-Agent AI Analysis